Psychopharmacological treatment status in outpatients with bipolar disorder: A clinical survey in Germany

Psychiatry Investigation

Volumn 7, Issue 3, 2010, Pages 155-162

  Quante, Arnim ^a   Zeugmann, Sara ^a   Regen, Francesca ^a   Engelhardt, Annette ^b   Anghelescu, Ion George ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Sanofi   (Germany)

Author keywords

Bipolar disorder; Mania; Pharmacotherapy; Quality of life

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GERMANY; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; MONOTHERAPY; OCCUPATION; OUTPATIENT; PATIENT SATISFACTION; PRACTICE GUIDELINE; PSYCHOLOGIC TEST; PSYCHOPHARMACOLOGY; RAPID CYCLING BIPOLAR DISORDER; TREATMENT DURATION; UNEMPLOYMENT;

EID: 77957741769     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.3.155     Document Type: Article

References (29)

1. Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000;48:445-457.
2. Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord 1994;31:91-96.
3. Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220-228. (Pubitemid 30080901)
4. Kupka RW, Akshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007;9:531-535.
5. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537.
6. The World Health Organisation. The World Health Report 2000-Health Systems: Improving Performance. [Homepage: http://www.who.int/whr/2000/en/]. 2000.
7. Yatham LN, Kennedy SH, O'Donovan C, Parikh SV, MacQueen G, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 2006;8:721-739.
8. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:1-50.
9. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment non-adherence among US bipolar disorder patients. Hum Psychopharmacol 2008;23:95-105. (Pubitemid 351359581)
10. Miller DS, Yatham LN, Lam RW. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. J Clin Psychiatry 2001;62:975-980.
11. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711-1722.
12. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163:232-239.
13. Baldessarini RJ. Enhancing treatment with psychotropic medicines. Bull Menninger Clin 1994;58:224-241.
14. Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997;33:87-91. (Pubitemid 27184199)
15. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 2006;8:232-241.
16. Lin D, Mok H, Yatham LN. Polytherapy in bipolar disorder. CNS Drugs 2006;20:29-42.
17. Baethge C, Baldessarini RJ, Mathiske-Schmidt K, Hennen J, Berghofer A, Muller-Oerlinghausen B, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry 2005;66:174-182. (Pubitemid 40314323)
18. Busch AB, Ling D, Frank RG, Greenfield SF. Changes in the quality of care for bipolar I disorder during the 1990s. Psychiatr Serv 2007;58:27-33.
19. Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clin Ther 2005;27:263-272. (Pubitemid 40462022)
20. Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder. Clin Ther 2008;30:1358-1374.
21. Darling CA, Olmstead SB, Lund VE, Fairclough JF. Bipolar disorder: medication adherence and life contentment. Arch Psychiatr Nurs 2008;22:113-126.
22. Goossens PJ, Hartong EG, Knoppert-van der Klein EA, van AT. Self-reported psychopathological symptoms and quality of life in outpatients with bipolar disorder. Perspect Psychiatr Care 2008;44:275-284.
23. Yen CF, Cheng CP, Huang CF, Yen JY, Ko CH, Chen CS. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission. Bipolar Disord 2008;10:617-624.
24. Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 2008;59:1175-1183.
25. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111.
26. Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ. Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 1993;38:S57-S61.
27. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE, Frye MA, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal of Psychiatry 2003;160:1252-1262.
28. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-1585.
29. Ardinell WA, Ettema JH. Symptom Checklist 90; SCL-90. Amsterdam: Harcourt Assessment B V;2005.